IRVINE, Calif., April 13, 2011 /PRNewswire/ — Two new studies
published in the current issue of Surgery for Obesity and
Related Diseases, a peer-reviewed journal, add to the large
body of scientific evidence which supports that the LAP-BAND®
Adjustable Gastric Banding System, made by Allergan, Inc. (NYSE:
AGN), is a safe and effective weight-loss procedure. One study
concluded that laparoscopic adjustable gastric banding (LAGB)
procedure can be safely performed in a community medical practice,
with patients experiencing meaningful excess weight loss. The
second study examined patients who received LAGB following the
failure of gastric bypass and found they achieved significant
weight loss two years post-banding procedure.
While a wealth of data has been published in the literature
worldwide, questions have recently been raised about the safety and
effectiveness of the LAP-BAND® System, specifically with
respect to average weight loss and complications. These two new
studies support that the advanced product technology of the
LAP-BAND® AP System, combined with surgical technique and
patient aftercare result in positive clinical outcomes. The
LAP-BAND® System has an 18-year safety and effectiveness
record, including almost 10-years in the United States, with more
than 650,000 procedures performed worldwide, leading to more than
two million patient years of exposure for the device.
Key Study Findings Published in Surgery for Obesity
and Related Diseases:
The first study, by James B. Ray, M.D., F.A.C.S. and Shahla Ray,
Ph.D., of the Center for Advanced Laparoscopic and Bariatric
Surgery, Bloomington, IN, followed one surgeon’s practice for five
years (March 30, 2004 to December 2, 2009) in which 442 LAGB
procedures were performed. The study found that on average
patients achieved 48 percent excess we
‘/>”/>
